GCG and diabetes mellitus: The regulation of gluconeogenesis through histone deacetylase (HDAC) inhibition and the potent stimulation of glucagon-like peptide-1 (GLP-1)-mediated insulin secretion highlight butyrate as a promising candidate for diabetes therapy.